PRPL vs TSLA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The company is in severe financial distress, evidenced by a critical Piotroski F-Score of 1/9 and a negative Price-to-Book ratio of -2.30, indicating negative shareholders' equity. While the company has maintained a healthy gross margin of 40.44% and modest revenue growth of 9.10%, these are overshadowed by consistent net losses and a catastrophic 5-year price decline of 98.2%. The lack of a Graham Number or Intrinsic Value calculation is a direct result of the company's negative earnings and equity. Overall, the deterministic health scores signal a high risk of insolvency.
Tesla's deterministic health is stable with a Piotroski F-Score of 4/9, but its valuation is fundamentally disconnected from current performance. The Graham Number ($22.85) and Intrinsic Value ($7.42) indicate extreme overvaluation relative to the current price of $343.25. With negative YoY revenue growth (-3.10%) and a collapse in earnings growth (-60.60%), the P/E ratio of 323.82 is unsustainable. Technical trends and insider activity are both strongly bearish, suggesting a significant correction is likely.
Compare Another Pair
Related Comparisons
PRPL vs TSLA: Head-to-Head Comparison
This page compares Purple Innovation, Inc. (PRPL) and Tesla, Inc. (TSLA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.